CARR EDWARD bought DNTH
September 17, 2026 · Form 4 insider transaction
CARR EDWARD bought 20,000 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $357.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$17.88
Total value
$357.6K
InsiderCARR EDWARD
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 17, 2026
Filing dateSeptember 18, 2026
Shares owned after20,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026.